Prostate Cancer - Results from #60

Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion. September 12, 2023

Germline Genetic Testing After Cancer Diagnosis. September 12, 2023

Real-world genetic testing patterns in metastatic castration-resistant prostate cancer. September 12, 2023

Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectom September 12, 2023

Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer. September 12, 2023

Racial/Ethnic Disparities in Prostate Cancer 5-Year Survival: The Role of Health-Care Access and Disease Severity. September 12, 2023

Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites. September 12, 2023

From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life. September 12, 2023

Clinical Significance of Radical Prostatectomy in Clinical Lymph Node Metastasis in Prostate Cancer. September 11, 2023

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy. September 11, 2023

Relative search popularity of five advanced prostate cancer medications using Google Trends. September 11, 2023

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis. September 11, 2023

Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification. September 11, 2023

A systematic review evaluating the effectiveness of exercise training on physical condition in prostate cancer patients undergoing androgen deprivation therapy. September 11, 2023

Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T. September 11, 2023

Application of next-generation imaging in biochemically recurrent prostate cancer. September 11, 2023

Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy. September 8, 2023

IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer. September 8, 2023

The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer. September 8, 2023

Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer. September 8, 2023

Page 4 of 1332